Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BHVN - Is XBI ETF A Buy Or Sell In 2022 For ETF Investors?


BHVN - Is XBI ETF A Buy Or Sell In 2022 For ETF Investors?

  • The outlook for the pharmaceutical and biotech industry is good thanks to resilience versus crises and large macro tailwinds.
  • XBI and many biotech names have sold off a lot over the last year. The ETF is now trading lower than before the pandemic.
  • XBI's approach is different from that of IBB and other ETFs, as it does not focus on the large-cap established names. Whether that's good or bad depends on your goals.

For further details see:

Is XBI ETF A Buy Or Sell In 2022 For ETF Investors?
Stock Information

Company Name: Biohaven Pharmaceutical Holding Company Ltd.
Stock Symbol: BHVN
Market: NYSE
Website: biohavenpharma.com

Menu

BHVN BHVN Quote BHVN Short BHVN News BHVN Articles BHVN Message Board
Get BHVN Alerts

News, Short Squeeze, Breakout and More Instantly...